CCL2 and endothelial dysfunction: In addition, studies have found that 17β-estradiol administration can effectively reduce the up-regulation of ACE2-dependent NOX2, MCP-1 and ROS, and alleviate endothelial dysfunction and multiple organ failure mediated by COVID-19 inflammation during the pathogenesis (Youn et al., 2021).